Cambios evolutivos en las tasas y fenotipos de resistencia de Streptococcus pyogenes en una población pediátrica de Asturias, España (2005-2015)

Calle-Miguel, Laura; Pérez-Méndez, Carlos; Miguel-Martínez, María Dolores; Lombraña-Álvarez, Emma; García-García, Elisa; Solís-Sánchez, Gonzalo.
Rev. esp. quimioter ; 30(2): 90-95, abr. 2017. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-161003

Documentos relacionados

  1. An assessment of the airborne longevity of group A Streptococcus.
  2. Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.
  3. Expansion of Invasive Group A Streptococcus M1<sub>UK</sub> Lineage in Active Bacterial Core Surveillance, United States, 2019‒2021.
  4. A multi-center clinical investigation on invasive Streptococcus pyogenes infection in China, 2010-2017.
  5. Efficacy and side-effect profile of tedizolid in the treatment of streptococcal toxic shock syndrome due to clindamycin-resistant Streptococcus pyogenes: A case report.
  6. Molecular characterization and antibiotic resistance of Streptococcus dysgalactiae subspecies equisimilis isolated from patients with streptococcal toxic shock syndrome.
  7. Group A Streptococcus induces GSDMA-dependent pyroptosis in keratinocytes.
  8. An optimized SpCas9 high-fidelity variant for direct protein delivery.
  9. Neutrophil-derived reactive agents induce a transient SpeB negative phenotype in Streptococcus pyogenes.
  10. Development of versatile affinity-based system for one step purification process: Case of Group A Streptococcus vaccine.